NCT04988555 2026-03-24A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)Sumitomo Pharma America, Inc.Phase 1/2 Recruiting606 enrolled
NCT04068597 2025-12-18Study to Evaluate CCS1477 (Inobrodib) in Haematological MalignanciesCellCentric Ltd.Phase 1/2 Recruiting250 enrolled